Table on assessment times for Concerned Member State cases

Updated 18 March 2025
Average assessment time Target days Difference between assessment time and target days No. of cases measured No. of Drug IDs No. of cases within 30 days Share of cases within 30 days in per cent
Concerned Member State cases
1st quarter 2023 112 30 82 75 31 41
2nd quarter 2023 89 30 59 80 23 29
3rd quarter 2023 57 30 27 116 55 47
4th quarter 2023 123 30 93 66 23 35
1st quarter 2024 69 30 39 84 36 43
2nd quarter 2024 87 30 57 112 55 49
3rd quarter 2024 116 30 86 150 59 39
4th quarter 2024 91 30 61 161 72 45
Table 2. Concerned member state cases – Human medicines
Average assessment time Target days Difference between assessment time and target days No. of cases measured No. of Drug IDs No. of cases within 30 days Share of cases within 30 days in per cent
Concerned Member State cases - HUM
1st quarter 2023 117 30 87 70 28 40
2nd quarter 2023 90 30 60 70 21 30
3rd quarter 2023 61 30 31 91 42 46
4th quarter 2023 135 30 105 59 18 31
1st quarter 2024 76 30 46 76 28 37
2nd quarter 2024 95 30 65 95 44 46
3rd quarter 2024 128 30 98 126 39 31
4th quarter 2024 95 30 65 152 66 43
Table 3. Concerned member state cases – Veterinary medicines
Average assessment time Target days Difference between assessment time and target days No. of cases measured No. of Drug IDs No. of cases within 30 days Share of cases within 30 days in per cent
Concerned Member State cases - VET
1st quarter 2023 35 30 5 5 3 60
2nd quarter 2023 80 30 50 10 2 20
3rd quarter 2023 42 30 12 25 13 52
4th quarter 2023 16 30 -14 7 5 71
1st quarter 2024 7 30 -23 8 8 100
2nd quarter 2024 44 30 14 17 11 65
3rd quarter 2024 57 30 27 24 20 83
4th quarter 2024 19 30 -11 9 6 67